Growth Metrics

Mangoceuticals (MGRX) Preferred Shares Issued (2024 - 2025)

Mangoceuticals recorded quarterly Preferred Shares Issued of -$1.0 million in Q2 2025, down 191.3% quarter-over-quarter from $1.2 million in Q1 2025.

Mangoceuticals' Preferred Shares Issued history runs 2 years deep, the most recent figure standing at -$1.0 million for Q2 2025.

  • In Q2 2025, Preferred Shares Issued changed N/A year-over-year to -$1.0 million; the TTM figure through Dec 2025 stood at $100000.0 (changed N/A YoY), while the FY2025 annual figure was $100000.0, down 96.23% from the prior year.
  • Preferred Shares Issued came in at -$1.0 million for Q2 2025 at Mangoceuticals, down from $1.2 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $1.2 million in Q1 2025 to a low of -$1.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares Issued (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn -
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Mangoceuticals 7.03 Mn 6.84 Mn 29,001.00 -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -1.05 Mn
Jun 30, 2025 -1.05 Mn
Mar 31, 2025 1.15 Mn
Mar 31, 2025 1.15 Mn
Dec 31, 2024 400,000.00
Dec 31, 2024 400,000.00
Sep 30, 2024 750,000.00
Sep 30, 2024 750,000.00